» Articles » PMID: 16302871

Epidemiology of Idiopathic Generalized Epilepsies

Overview
Journal Epilepsia
Specialty Neurology
Date 2005 Nov 24
PMID 16302871
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

Idiopathic generalized epilepsies (IGEs) are a relatively new category of disorders defined by strict clinical and electroencephalogram (EEG) features proposed by the International League Against Epilepsy (ILAE) classification of epileptic syndromes. IGEs are usually easy to diagnose when clinical and EEG data are collected, but epilepsy is not synonymous with epileptic syndrome. So far, IGEs are studied in the large group of epilepsies of undetermined or unknown etiology although the genetic origin is now largely accepted. ILAE-proposed criteria are helpful in the clinical and therapeutic management of IGEs, but many epidemiologic studies still confuse the cryptogenic and idiopathic groups. Some syndromes in childhood, which are completely described by strict electroclinical criteria such as the absence epilepsies, juvenile myoclonic epilepsies, are usually included and analyzed in epidemiologic studies; however, other epileptic syndromes observed in infancy, such as benign familial neonatal seizures and benign myoclonic epilepsy in infancy, are quite rare and are usually excluded from epidemiologic surveys because they are difficult to describe completely in electro-clinical terms. Another strong limitation in the study of epidemiology of IGEs is the lack of EEG data, either because EEG is not available or the routine EEG is normal. This is particularly relevant in the inclusion of patients with only tonic-clonic seizures. IGEs encompass several different syndromes, and a few patients shift from one phenotype to another. The overlapping of some syndromes during infancy and adolescence increased the difficulty to individualize strictly the correct syndrome. Many discrepancies can be observed in the distribution of the different syndromes included in the group of IGEs, because the strict criteria for classifying these syndromes proposed by the ILAE are often not respected. With this understanding, the general frequency of IGEs can be assessed at 15-20% of all epilepsies. The frequency and the distribution of incidence and prevalence of the different syndromes are tentatively reported and discussed. When the term idiopathic is used following the restrictive ILAE criteria, the mortality data concerning patients with idiopathic epilepsies do not show an increased standardized mortality ratio.

Citing Articles

Second-Line Medications for Women Aged 10 to 50 Years With Idiopathic Generalized Epilepsy.

Cerulli Irelli E, Cocchi E, Gesche J, Pena-Ceballos J, Caraballo R, Lattanzi S JAMA Netw Open. 2025; 8(3):e250354.

PMID: 40063025 PMC: 11894492. DOI: 10.1001/jamanetworkopen.2025.0354.


Association of valproate use and hippocampal atrophy in idiopathic generalized epilepsy.

Huang X, Zhang Y, Lin Q, Huang K, Li Y, Liu P Neuroimage Clin. 2025; 45:103744.

PMID: 39914290 PMC: 11847523. DOI: 10.1016/j.nicl.2025.103744.


Felbamate as a therapeutic alternative to drug-resistant genetic generalized epilepsy: a systematic review and meta-analysis.

Ma Y, Kaminski M, Crutcher R Neurol Sci. 2024; .

PMID: 39724322 DOI: 10.1007/s10072-024-07942-6.


A Comprehensive Overview of the Current Status and Advancements in Various Treatment Strategies against Epilepsy.

Waris A, Siraj M, Khan A, Lin J, Asim M, Alhumaydh F ACS Pharmacol Transl Sci. 2024; 7(12):3729-3757.

PMID: 39698272 PMC: 11650742. DOI: 10.1021/acsptsci.4c00494.


Comparative analysis of processing speed impairments in TLE, FLE, and GGE: Theoretical insights and clinical Implications.

Falah A, Winston G Epilepsy Behav Rep. 2024; 28:100722.

PMID: 39534465 PMC: 11555411. DOI: 10.1016/j.ebr.2024.100722.